menu
    • menu

    Company profile for RAPTOR PHARMS

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.https://marketing.lgmpharma.com/LGM-CDMO

    Virtual Booth

    Contact Supplier

    Vamsi Labs is one of the major manufacturers of Anti-asthmatic, Anti-migraine & Anti-psychotic APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Raptor Pharmaceutical Corp. (NASDAQ: RPTP) is an emerging global biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat rare, debilitating and often fatal diseases. Raptor’s first product, PROCYSBI® (cysteamine bitartrate) delayed-release capsules, received FDA approval in April 2013 for the management of nephropathic cystinosis in adults and children 6 years and older. In...
    Raptor Pharmaceutical Corp. (NASDAQ: RPTP) is an emerging global biopharmaceutical company focused on developing and commercializing life-altering therapeutics that treat rare, debilitating and often fatal diseases. Raptor’s first product, PROCYSBI® (cysteamine bitartrate) delayed-release capsules, received FDA approval in April 2013 for the management of nephropathic cystinosis in adults and children 6 years and older. In Europe, PROCYSBI® gastro-resistant hard capsules of cysteamine (as mercaptamine bitartrate) received European Commission approval in September 2013 for the treatment of proven nephropathic cystinosis. The company has active clinical development programs in multiple therapeutic areas such as nephropathic cystinosis, nonalcoholic fatty liver disease, Huntington’s disease (HD), and Leigh syndrome and other mitochondrial disease. Raptor holds several orphan drug designations, including U.S. orphan drug designation for RP103 in Huntington’s disease. Raptor holds intellectual property for the use of cysteamine in HD and other neurodegenerative disorders including Parkinson’s disease, Rett and the treatment of MeCP2-associated disorders. For additional information, please visit Products & Pipeline.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    RAPTOR PHARMSUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Raptor Pharmaceutical Corp. 7 Hamilton Landing, Suite 100 Novato, CA 94949
    Telephone
    Telephone
    1-415-408-6200
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Horizon Seals $800m Raptor Buy
    Horizon Seals $800m Raptor Buy

    27 Oct 2016

    // Selina McKee PHARMATIMES

    http://www.pharmatimes.com/news/horizon_seals_$800m_raptor_buy_1174587

    Selina McKee PHARMATIMES
    27 Oct 2016
    Share Share
    How These Biotech Stocks are Faring? -- Raptor, Amicus, Neuralstem, & Macrocure
    How These Biotech Stocks are Faring? -- Raptor, Amicus, Neuralstem, & Macrocure

    21 Oct 2016

    // PRNEWSWIRE

    http://www.prnewswire.com/news-releases/how-these-biotech-stocks-are-faring----raptor-pharma-amicus-therapeutics-neuralstem-and-macrocure-597893351.html

    PRNEWSWIRE
    21 Oct 2016
    Share Share
    More Rare Disease Deal making to Follow Horizon's Raptor Deal
    More Rare Disease Deal making to Follow Horizon's Raptor Deal

    13 Sep 2016

    // Sarah Pringle THE STREET

    https://www.thestreet.com/story/13727391/1/more-rare-disease-dealmaking-to-follow-horizon-s-raptor-deal.html

    Sarah Pringle THE STREET
    13 Sep 2016
    Share Share
    Horizon Pharma in $800M Raptor rare disease buy, but pipeline beset by failures
    Horizon Pharma in $800M Raptor rare disease buy, but pipeline beset by failures

    13 Sep 2016

    // Ben Adams FIERCE BIOTECH

    http://www.fiercebiotech.com/biotech/horizon-pharma-800m-raptor-rare-disease-buy-but-pipeline-beset-by-failures

    Ben Adams FIERCE BIOTECH
    13 Sep 2016
    Share Share
    After failing a PhII/III, Raptor steers Huntington's drug into a pivotal trial
    After failing a PhII/III, Raptor steers Huntington's drug into a pivotal trial

    10 Dec 2015

    // John Carroll FIERCE BIOTECH

    http://www.fiercebiotech.com/story/after-failing-phiiiii-raptor-steers-huntingtons-drug-pivotal-trial/2015-12-10

    John Carroll FIERCE BIOTECH
    10 Dec 2015
    Share Share
    Raptor plans to advance development of brain disorder drug
    Raptor plans to advance development of brain disorder drug

    10 Dec 2015

    // Shailesh Kuber REUTERS

    http://www.reuters.com/article/us-raptor-pharmactl-study-idUSKBN0TT1NV20151210#kA0zE5R5OiRKO67T.97

    Shailesh Kuber REUTERS
    10 Dec 2015
    Share Share

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search